About
Laboratories
NSG Bio Labs@Biopolis
NSG Bio @Geneo (Coming Soon)
NSG Bio Tomorrow
About
Why NSG Bio?
Programmes
Get in touch
Senti Bio Announces Positive Initial Clinical Data in Phase 1 Clinical Trial of SENTI-202
by
John Lam
on
December, 2024
in
Press & Media
Previous Reading
NSG BioLabs and Merck Collaborates to Support Biotech Start-ups to Advance Research & Innovations
Next Reading
Thermo Fisher Scientific, NSG BIO Collaborate to Strengthen Singapore’s Biotech Startup Ecosystem
×
About
Laboratories
NSG Bio Labs@Biopolis
NSG Bio @Geneo (Coming Soon)
NSG Bio Tomorrow
About
Why NSG Bio?
Programmes
Get in touch
About
Laboratories
NSG Bio Labs@Biopolis
NSG Bio @Geneo
NSG Bio Tomorrow
About
Why NSG Bio?
Programmes
Get in touch
Press & Media
Partners
Our Locations
×
What are you looking for?
Search for:
